Genmab A/S

Stocks

Real-time Estimate Cboe Europe 01:32:46 31/10/26 am AEDT			5-day change	1st Jan Change
3,862.50 ^DKK	+1.97%		+46.14%	+90.63%

12:40am	AlphaValue/Baader Europe Upgrades Genmab to Reduce	MT
30/10	Deutsche Bank raises price target for Genmab to DKK 4,000 (3,500), reiterates buy - BN	FW

Published on 10/29/2026 at 04:50 am AEDT - Modified on 10/29/2026 at 08:25 am AEDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome to Genmab's Investor Event. [Operator Instructions] As a reminder, this conference is being recorded today. If you have any

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

12:40am	AlphaValue/Baader Europe Upgrades Genmab to Reduce	MT
30/10	Deutsche Bank raises price target for Genmab to DKK 4,000 (3,500), reiterates buy - BN	FW
30/10	AlphaValue/Baader Europe Downgrades Genmab to Sell	MT
30/10	Not All AI Billions Are Equal
29/10	Goldman Sachs raises its price target for Genmab to 4,450 Danish kroner (2,400), reiterates buy	FW
29/10	Genmab: Positive developments priced in; time to take profits
29/10	SEB raises price target for Genmab to DKK 4,600 (3,175), reiterates buy	FW
29/10	DNB Carnegie downgrades Genmab to hold (buy), target price DKK 4,100 (3,100)	FW
29/10	Jyske Bank cuts Genmab to sell (hold), price target DKK 3,725 - BN	FW
29/10	Alphabet Takes Some of the Shine Off the AI Party
29/10	Nordea raises price target for Genmab to 4,500 Danish kroner (3,200), reiterates Buy	FW
29/10	Sydbank lowers Genmab to hold (buy) - BN	FW
29/10	TD Cowen raises price target for Genmab to DKK 4,526 (3,435), reiterates buy - LSEG	FW
29/10	Barclays raises price target for Genmab to 4,500 Danish kroner (3,400), reiterates overweight	FW
29/10	Genmab A/S - Special Call